Healthcare Performance Improvement & Advisory Firm, 40-Year California Operator

$3.9M

Revenue

$1.5M

SDE

Subscribe Free

Read the full deal writeup

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is a 40-year-old healthcare performance-improvement and advisory firm based in Los Angeles that helps hospitals, health systems, community health centers and clinic networks improve patient experience, workforce engagement, leadership effectiveness and overall organizational performance. The delivery model blends advisory consulting, implementation services, digital/SaaS learning, AI-enabled tools and a proprietary library of healthcare education and leadership content. It generates roughly $3.9 million in revenue at a 22.6% EBITDA margin, with 100% of revenue coming from U.S. customers.

The business runs a national, distributed delivery model combining onsite and virtual engagement, so it is light on physical facilities and heavy on intellectual property and client relationships. A recurring revenue dynamic exists via multi-year implementation engagements, repeat advisory work and an established annual industry conference that functions as a lead-generation and retention engine. That conference community is a genuine differentiator that most consulting-style competitors cannot easily replicate.

What makes this notable is the combination of durable multi-year client contracts, proprietary IP that can be redeployed across larger networks, and a founder pursuing a planned retirement who is willing to stay on in an ambassador capacity. The core offering, helping healthcare organizations operate better, sits in a non-discretionary vertical where improving patient experience and retention is a budget priority even in downturns. The chief risks center on founder-dependence and understanding exactly how much revenue is contracted versus project-based.

Why we like it

Earnings quality looks solid with roughly $3.9M revenue converting to $1.53M of SDE and $871k of EBITDA at a stated 22.6% margin. Multi-year implementation engagements and repeat advisory work suggest a meaningful contracted base rather than purely one-off project revenue, which supports earnings predictability.
The moat is built on 40 years of proprietary IP, a large library of healthcare education and leadership content, and an annual industry conference that creates a community few competitors can copy. These assets are sticky because switching mid-way through a multi-year behavior-change program is costly and disruptive for hospital clients.
The tailwind is real: healthcare organizations face relentless pressure on patient experience scores, workforce retention and reimbursement tied to performance metrics. This firm sells into a non-discretionary priority where boards and executives keep spending even when budgets tighten elsewhere.
There is a clear operator advantage for a strategic buyer already serving healthcare clients. Cross-selling this firm's advisory and SaaS offerings into an existing customer base, or plugging its content into a larger distribution channel, offers a credible path to expand both top line and margins with real operating leverage.

How to improve it

Audit the revenue mix in the first 90 days to separate contracted multi-year implementation fees from one-time project and conference revenue. Knowing the true recurring base lets you reprice renewals, lengthen contract terms, and underwrite the business accurately rather than paying for project revenue as if it were an annuity.
Push expansion of wallet share within the existing long-term client relationships, which the listing flags explicitly. Build a structured land-and-expand motion that moves single-service clients into enterprise agreements spanning advisory, SaaS and content across more of their facilities.
Scale the digital, SaaS and AI-enabled offerings aggressively because they carry the highest incremental margins. Converting more of the proprietary library into a self-serve or hybrid subscription product reduces reliance on billable consulting hours and improves margin and multiple.
Attack the founder-dependence risk immediately by documenting methodologies, codifying the IP, and elevating a bench of senior delivery leaders. The founder staying as an ambassador buys time, but the goal is making client relationships stick to the firm and the brand rather than to one person.
Monetize the annual conference more deliberately as a growth engine. Add sponsorship tiers, paid workshops, recorded content libraries, and a structured post-event sales funnel to convert attendees into multi-year clients and raise event-driven revenue.
Implement pricing discipline and standardize scoping across engagements. The listing itself cites margin improvement through pricing and technology-enabled delivery, so tightening proposal pricing and reducing custom one-off delivery should lift the 22.6% EBITDA margin.

Diligence notes

Quantify the true recurring revenue. Get the contract roster showing engagement length, renewal rates, remaining backlog and how much revenue is contracted versus project-based, because the valuation hinges on whether this is an annuity or a sequence of re-won projects.
Measure founder concentration in both client relationships and revenue generation. Determine how many engagements the founder personally sources or leads, since an ambassador role only mitigates the risk if clients and sales do not depend on his presence.
Assess customer concentration and the health of the top accounts. With roughly $3.9M in revenue, a handful of large hospital or health-system contracts could represent a disproportionate share, so review renewal timing and relationship depth for the top five to ten clients.
Validate the SaaS and AI claims and the condition of the proprietary IP. Confirm what is genuinely productized software with its own revenue versus marketing framing, and verify ownership, licensing and defensibility of the content library and tools.
Scrutinize the gap between $1.53M SDE and $871k EBITDA to understand owner add-backs and normalized cost structure. Identify which founder compensation, discretionary costs, and delivery expenses are truly non-recurring versus required to run the business post-sale.

Source

Originally listed on BizBuySell. View original listing →